Presentation NY Valves 2024 3 Reasons Why… I Would Recommend a Mechanical Valve Presenter: Michael J. Mack June 05, 2024
News Daily News Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World Shelley Wood February 19, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Conference News STS 2024 STS Survey Identifies Stark Gender Disparities in Compensation Yael L. Maxwell January 30, 2024
News Daily News Family History of CVD? Low PUFA Intake May Add to Risk Michael O'Riordan December 12, 2023
Presentation Controversies and Advances 2023 Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward Presenter: Michael Mack November 30, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
Presentation TVT 2023 Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective Presenter: Michael Mack June 08, 2023
Presentation TVT 2023 Putting “Lifetime” Into Perspective (How Long Do Patients With AS / AVR Actually Survive) Presenter: Michael Mack June 08, 2023
News Conference News TVT 2022 Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry Michael O'Riordan June 13, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2022 Shelley Wood May 02, 2022
News Daily News The NCDR Has Made a Difference, but Experts See Room for Growth Todd Neale April 28, 2022
News Conference News ACC 2022 Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM Yael L. Maxwell April 02, 2022
News Conference News ACC 2022 POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery Todd Neale April 02, 2022
Presentation Controversies and Advances 2021 Heart Valve Collaboratory Presenter: Michael Mack December 03, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021